doi: 10.1038/s41574-024-00983-z
In addition to its effects on blood sugar, GLP-1 also influences your appetite, gastric emptying, and body weight
Shotgun metagenomics, from sampling to analysis
This medication mimics the activity of the GLP-1 hormone, which is responsible for regulating your bodys sugar level and metabolic health
Furthermore, an increase in the intragastric pH, observed during GLP-1 RAs therapy, may also alter the absorption of medications ( 4.1.4 Mortality and adverse events The available evidence demonstrates that GLP-1 RAs therapy reduces all-cause mortality in T2DM, including patients with chronic kidney disease and increased cardiovascular risk ( Patients receiving GC therapy represent a highly heterogeneous group, including individuals with SID, short-term hyperglycemia in previously normoglycemic patients initiating GC therapy, SIH in patients with T2DM and PTDM